US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 5.540
  • +0.070+1.28%
Close Jul 12 16:00 ET
  • 5.540
  • 0.0000.00%
Post 19:58 ET
455.60MMarket Cap-2676P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Editas Medicine Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

1.14M

-88.48%
EPS(YoY)

-0.76

-7.04%
Analyst Rating

Buy

Jul 14, 2024

Editas Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.289M--
--2024/Q2-- / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--
Feb 28, 20242023/Q460.049M / 14.311M--
Nov 3, 20232023/Q35.336M / 3.419M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.289M--
--2024/Q2-- / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--
Feb 28, 20242023/Q460.049M / 14.311M--
Nov 3, 20232023/Q35.336M / 3.419M--

Unlock Free Earnings Estimates

Editas Medicine Earnings Reports

  • Editas Medicine | 10-Q: Quarterly report

    May 8 17:04 ET

  • Editas Medicine | 10-K: Annual report

    Feb 28 16:20 ET

  • Editas Medicine | 10-Q: Q3 2023 Earnings Report

    Nov 3, 2023 16:03 ET

  • Editas Medicine | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 16:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 14, 2024

    Buy

    • Buy

      30.00%

    • Hold

      70.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Gene Editing
    Gene Editing
    Intraday-0.03%